Associate Professor Keiichi Sumida of UTHSC Receives $2.9 Million to Study Alternative Cause of Chronic Inflammation in Kidney Disease
July 11, 2020
July 11, 2020
MEMPHIS, Tennessee, July 11 -- The University of Tennessee Health Science Center issued the following news:
Patients with end stage renal disease (ESRD) face an increased risk of death due in part to cardiovascular problems caused by chronic inflammation. Efforts to reduce this inflammation have tended to target dialysis-related procedures and the accumulation of toxic waste products. These efforts have been largely unsuccessful, and researchers, such as Keiichi Sumida, MD, MPH, PhD . . .
Patients with end stage renal disease (ESRD) face an increased risk of death due in part to cardiovascular problems caused by chronic inflammation. Efforts to reduce this inflammation have tended to target dialysis-related procedures and the accumulation of toxic waste products. These efforts have been largely unsuccessful, and researchers, such as Keiichi Sumida, MD, MPH, PhD . . .